After surgery
Controversies & future directions
Vestibular surgery still carries genuine debates — and a future that is tilting from removing broken structures toward restoring them.
The live controversies
Several decisions remain genuinely unsettled, and honest practice means acknowledging them:
| Debate | Where it stands |
|---|---|
| Does endolymphatic sac surgery work? | A landmark double-blind trial found no difference from sham mastoidectomy, fuelling a placebo debate; later series are mixed. It remains a hearing-sparing option in carefully selected patients. |
| Surgery vs intratympanic gentamicin for Ménière's | Gentamicin is less invasive and titratable but risks hearing loss and bilateral damage; neurectomy is more definitive but more invasive. No head-to-head RCTs exist. |
| SSCD: middle fossa vs transmastoid | Middle fossa gives direct visualisation but needs a craniotomy; transmastoid is less invasive but limited access. No consensus gold standard. |
| Expectations vs outcomes | Objective vertigo control does not guarantee satisfaction — persistent imbalance, oscillopsia and psychological factors matter. Counselling must align expectations with the likely course. |
The endolymphatic-sac debate is the emblem: a double-blind trial found it no better than sham mastoidectomy,1 yet it persists as a hearing-sparing option. Likewise, the choice between surgery and intratympanic gentamicin lacks head-to-head trials,2 and there is no consensus gold standard for the SSCD approach.3
Minimally invasive techniques
Technique is moving toward less morbidity and more precision: transcanal endoscopic-assisted canal procedures that avoid a mastoidectomy, image-guided navigation for accurate targeting in SSCD, intraoperative neurophysiological monitoring to protect the facial and cochlear nerves, and better biomaterials (hydroxyapatite, composite grafts) that lower recurrence after canal repair.4 Robot-assisted microsurgery, offering sub-millimetre precision in the temporal bone, is in early development.
From ablation to restoration
The most striking shift is in direction of travel — away from destroying vestibular structures and toward restoring them:
- Vestibular implants — cochlear-implant-like neuroprostheses delivering motion-encoded stimulation to the vestibular nerve, with early human evidence of improved gaze and postural control in bilateral loss.5
- Regenerative medicine — gene therapy (e.g. Atoh1) and stem-cell-derived progenitors aiming to regenerate vestibular hair cells, still preclinical but advancing.6
- Artificial intelligence — pattern recognition across vestibular testing and imaging to refine candidate selection and surgical planning.
- Virtual-reality rehabilitation — immersive, graded sensory-conflict training to accelerate post-operative compensation.
Key points
- Endolymphatic sac surgery’s efficacy, surgery-vs-gentamicin, and the SSCD approach remain debated.
- Endoscopic, navigation-guided and monitored techniques are reducing morbidity.
- Vestibular implants and regenerative therapy point from ablation toward restoration.
- AI and VR rehabilitation are emerging adjuncts to selection and recovery.